May 19, 2010 — A voluntary recall has been issued for all lots of Baxter's hyaluronidase human injection (Hylenex) because of the presence of particulate matter, identified as glass, according to a ...

Dec. 8, 2005 — The US Food and Drug Administration (FDA) has approved bivalirudin injection for use in patients with or at risk of heparin-induced thrombocytopenia and thrombosis syndrome undergoing ...

DEERFIELD, Ill., May 17, 2010 (BUSINESS WIRE) -- Baxter International Inc. announced today that a voluntary recall of all manufactured lots of HYLENEX recombinant (hyaluronidase human injection) has ...

Baxter announced a voluntary recall of all lots of Hylenex recombinant (hyaluronidase human injection) as a precautionary measure due to instances of particulate matter observed in a limited number of ...

Baxter International Inc. (NYSE: BAX) today announced the commercial launch of HYLENEX recombinant (hyaluronidase human injection) for use in pediatric rehydration at the 2009 American College of ...

Halozyme Therapeutics has identified a corrective action plan to get its Hylenex pediatric-rehydration product back on the market. It completed a manufacturing root cause investigation and is prepping ...

TEL AVIV (MarketWatch) -- The U.S. Food and Drug Administration cleared Halozyme Therapeutics Inc.'s Hylenex recombinant for use as an adjuvant agent to increase the absorption and dispersion of ...

Agreement includes $10 million upfront and a $20-million equity investment. Halozyme Therapeutics and Baxter Healthcare expanded their existing Hylenex recombinant (hyaluronidase human injection) ...

Blac Chyna underwent a sixth procedure to dissolve her facial fillers after they “migrated down” her face. On Monday, the former OnlyFans model documented herself getting another round of Hylenex ...

FDA approved a Cook Pharmica facility and a Patheon facility for manufacturing of Halozyme products. Halozyme Therapeutics received FDA approval for two new contract manufacturing facilities used in ...